-
- Antigène Voir toutes BACE1 Kits
- BACE1 (Beta-secretase 1 (BACE1))
- Méthode de détection
- Fluorometric
- Application
- Activation (Act), Fluorescence Resonance Energy Transfer Microscopy (FRET)
- Marque
- SensoLyte®
- Attributs du produit
- The SensoLyte® 520 beta-Secretase Assay Kit is a homogeneous assay that can be used to detect the activity of enzyme and for screening of secretase inhibitors. It contains a QXL® 520/ HiLyte Fluor™ 488 FRET substrate. The sequence of this FRET peptide is derived from the beta-secretase cleavage site on the Swedish APP mutation. This mutation causes the enhancement of beta-secretase to process APP, resulting in an early onset of AD. Active beta-secretase cleaves FRET substrate into two separate fragments resulting in the release of HiLyte Fluor™ 488 fluorescence that can be monitored at excitation/emission= 490/520 nm. The long wavelength fluorescence of HiLyte Fluor™ 488 is less interfered by the autofluorescence of components in biological samples and test compounds.
- Top Product
- Discover our top product BACE1 Kit ELISA
-
-
- Commentaires
-
FRET-based Assay Kit
- Restrictions
- For Research Use only
-
- Stock
- -80 °C
- Stockage commentaire
- Store all kit components at -20 °C, except for Component F. Store b-secretase (Component F) at -80 °C. Protect Components A and B from light and from moisture. Components D and E can be stored at room temperature for convenience.
-
-
Inhibiting ?-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP." dans: Journal of molecular biology, Vol. 405, Issue 2, pp. 436-47, (2011) (PubMed).
: "Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production." dans: The Journal of biological chemistry, Vol. 283, Issue 27, pp. 18694-701, (2008) (PubMed).
: "Effect of mycelial extract of Clavicorona pyxidata on the production of amyloid beta-peptide and the inhibition of endogenous beta-secretase activity in vitro." dans: Journal of microbiology (Seoul, Korea), Vol. 44, Issue 6, pp. 665-70, (2007) (PubMed).
: "
-
Inhibiting ?-secretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP." dans: Journal of molecular biology, Vol. 405, Issue 2, pp. 436-47, (2011) (PubMed).
-
- Antigène
- BACE1 (Beta-secretase 1 (BACE1))
- Autre désignation
- BACE1 (BACE1 Produits)
- Synonymes
- ASP2 Kit, BACE Kit, HSPC104 Kit, C76936 Kit, Bace Kit, MGC145931 Kit, BACE1 Kit, zgc:77409 Kit, beta-secretase 1 Kit, beta-site APP cleaving enzyme 1 Kit, beta-site APP-cleaving enzyme 1 Kit, BACE1 Kit, Bace1 Kit, bace1 Kit
- Sujet
- Beta-Secretase is a membrane-anchored aspartic protease existing in acidic subcellular vesicles. It is a key player in producing beta-amyloid peptides through proteolytic cleavage of the beta-amyloid precursor protein (APP). Accumulation of neurotoxic beta-amyloid peptide is seen in senile plaques in the brains of patients with Alzheimer's disease (AD), an age-related cognitive disorder. Therefore, targeting beta-secretase is considered a potential therapeutic strategy for the prevention and treatment of AD.
-